Bioasis Technologies Stock Gross Profit
| BTI Stock | CAD 0.01 1.25 99.60% |
biOasis Technologies fundamentals help investors to digest information that contributes to British Amer's financial success or failures. It also enables traders to predict the movement of British Stock. The fundamental analysis module provides a way to measure British Amer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to British Amer stock.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 697.3 K | 761.4 K | |
| Gross Profit Margin | (0.15) | (0.13) |
British | Gross Profit |
biOasis Technologies Company Gross Profit Analysis
British Amer's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current British Amer Gross Profit | (1.19 M) |
Most of British Amer's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, biOasis Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
British Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for British Amer is extremely important. It helps to project a fair market value of British Stock properly, considering its historical fundamentals such as Gross Profit. Since British Amer's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of British Amer's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of British Amer's interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, biOasis Technologies reported (1.19 Million) of gross profit. This is 100.05% lower than that of the Biotechnology sector and 100.13% lower than that of the Health Care industry. The gross profit for all Canada stocks is 100.0% higher than that of the company.
British Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses British Amer's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of British Amer could also be used in its relative valuation, which is a method of valuing British Amer by comparing valuation metrics of similar companies.British Amer is currently under evaluation in gross profit category among its peers.
British Fundamentals
| Return On Asset | -0.81 | ||||
| Operating Margin | (4.69) % | ||||
| Current Valuation | 2.45 M | ||||
| Shares Outstanding | 79.41 M | ||||
| Shares Owned By Insiders | 2.05 % | ||||
| Number Of Shares Shorted | 105.04 K | ||||
| Price To Earning | 25.91 X | ||||
| Price To Book | 54.04 X | ||||
| Price To Sales | 1.47 X | ||||
| Revenue | 269.38 K | ||||
| Gross Profit | (1.19 M) | ||||
| EBITDA | (2.98 M) | ||||
| Net Income | (2.96 M) | ||||
| Cash And Equivalents | 2.68 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 1.9 M | ||||
| Debt To Equity | 0.31 % | ||||
| Current Ratio | 1.70 X | ||||
| Book Value Per Share | (0.03) X | ||||
| Cash Flow From Operations | (3.64 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 2.0 | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 397.07 K | ||||
| Total Asset | 2.27 M | ||||
| Retained Earnings | (40.65 M) | ||||
| Working Capital | (882.74 K) | ||||
| Net Asset | 2.27 M |
About British Amer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze biOasis Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of British Amer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of biOasis Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for British Stock Analysis
When running British Amer's price analysis, check to measure British Amer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy British Amer is operating at the current time. Most of British Amer's value examination focuses on studying past and present price action to predict the probability of British Amer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move British Amer's price. Additionally, you may evaluate how the addition of British Amer to your portfolios can decrease your overall portfolio volatility.